CCA INDUSTRIES, INC. is engaged in the health and beauty aids business with a line of health and beauty aids products which it has manufactured on its behalf under its formulations.
| Revenue (Most Recent Fiscal Year) | $7.74M |
| Net Income (Most Recent Fiscal Year) | $-6.12M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.78 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.71 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -20.48% |
| Net Margin (Trailing 12 Months) | -80.62% |
| Return on Equity (Trailing 12 Months) | -96.03% |
| Return on Assets (Trailing 12 Months) | -71.60% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.33 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.45 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.40 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.50 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.77 |
| Exchange | NYSEMKT |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Common Shares Outstanding | 6.59M |
| Free Float | 4.61M |
| Market Capitalization | $5.70M |
| Average Volume (Last 20 Days) | 2224.15 |
| Beta (Past 60 Months) | 0.54 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 30.12% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |